Exercise News and Research RSS Feed - Exercise News and Research

DaVita's HealthCare Partners division celebrates National Men's Health Month

DaVita's HealthCare Partners division celebrates National Men's Health Month

HealthCare Partners, a division of DaVita HealthCare Partners Inc., celebrates the month of June – National Men's Health Month – by recognizing the importance of bringing awareness to the health care issues that affect men. [More]
Weight loss, combined with vitamin D supplements, reduces chronic inflammation

Weight loss, combined with vitamin D supplements, reduces chronic inflammation

For the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight loss, in combination with vitamin D supplementation, has a greater effect on reducing chronic inflammation than weight loss alone. Chronic inflammation is known to contribute to the development and progression of several diseases, including some cancers. [More]
UC Riverside researchers explore effects of early-life exercise

UC Riverside researchers explore effects of early-life exercise

More than one in three adults in the United States is considered to be obese. What impact can exercise done early in life have on the propensity for exercising during the adult years? A team of researchers at the University of California, Riverside did experiments on mice in the lab to find out. Specifically, they evaluated the effects of early exercise on adult physical activity, body mass, food consumption and circulating leptin levels. [More]
Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris Inc. announced today that it has executed a definitive agreement with Ergomed PLC, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD"). [More]
Impax Laboratories prices convertible senior notes due 2022 in private offering

Impax Laboratories prices convertible senior notes due 2022 in private offering

Impax Laboratories, Inc. priced $500,000,000 aggregate principal amount of 2.00% convertible senior notes due 2022 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). [More]
Weight loss along with vitamin D supplementation reduces chronic inflammation

Weight loss along with vitamin D supplementation reduces chronic inflammation

For the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight loss, in combination with vitamin D supplementation, has a greater effect on reducing chronic inflammation than weight loss alone. [More]
Omega-3 Coalition forms scientific advisory council to educate consumers about benefits, safety of omega-3s

Omega-3 Coalition forms scientific advisory council to educate consumers about benefits, safety of omega-3s

The Omega-3 Coalition, a group of industry stakeholders working to improve consumer knowledge of omega-3s, today announced the formation of a scientific advisory council. [More]
Noisy road traffic may reduce life expectancy, increase stroke risk

Noisy road traffic may reduce life expectancy, increase stroke risk

Living in an area with noisy road traffic may reduce life expectancy, according to new research published in the European Heart Journal. [More]
Brainpaths neurological device stimulates brain‘s sensory cortex

Brainpaths neurological device stimulates brain‘s sensory cortex

Brainpaths is a BREAKTHROUGH: a Neurological Medical Device that stimulates the sensory cortex of the brain; Brainpaths Medical Device is non-powered, approved for home use and can be purchased without a prescription for under $40. [More]

NYU Steinhardt creates Marilyn Moffat Endowed Chair in Physical Therapy to support faculty member

NYU's Steinhardt School of Culture, Education, and Human Development has created the Marilyn Moffat Endowed Chair in Physical Therapy to support a faculty member dedicated to advancing physical therapy through research, teaching, and practice. [More]
BiondVax Pharmaceuticals declares closing of over-allotment option granted to underwriters

BiondVax Pharmaceuticals declares closing of over-allotment option granted to underwriters

​BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced the closing of an additional and partial exercise of the over-allotment option granted to the underwriters. [More]
'Fitness' foods encourage people to eat more, exercise less

'Fitness' foods encourage people to eat more, exercise less

Weight-conscious consumers are often drawn to foods such as Clif Bars and Wheaties, whose packaging suggests that they promote fitness. But according to a new study in the Journal of Marketing Research, such "fitness branding" encourages consumers to eat more of those foods and to exercise less, potentially undermining their efforts to lose or control their weight. [More]
Researchers looking to enroll patients in groundbreaking NIH diabetes study

Researchers looking to enroll patients in groundbreaking NIH diabetes study

Maria Gaona has been battling diabetes for eight years. Coupled with a family history of the disease, poor eating habits and no exercise regimen, the 64-year-old faces a lifetime of daily medications to control her disease. Fortunately, in 2014, she enrolled in a groundbreaking national research study that has already helped her control her glucose level, lose 16 pounds and regulate her daily medications. [More]
DC Devices announces completion of enrollment in REDUCE LAP-HF trial for diastolic heart failure treatment

DC Devices announces completion of enrollment in REDUCE LAP-HF trial for diastolic heart failure treatment

DC Devices, Inc., a medical device company pioneering first-in-class structural heart devices for heart failure, today announced that it has completed enrollment and implants in the REDUCE LAP-HF trial, an open label, multi-center, single-arm study of the InterAtrial Shunt Device (IASD) – the world's first transcatheter device for the treatment of diastolic heart failure (DHF), which is also known as heart failure with preserved ejection fraction (HFpEF). [More]
Research: Patients test drive pacemaker outside the skin before deciding on permanent implant

Research: Patients test drive pacemaker outside the skin before deciding on permanent implant

Patients are test driving a pacemaker outside the skin before deciding whether to have a permanent implant, reveals novel research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Professor Michael Giudici, director of arrhythmia services in the Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, US. [More]
Warming climate trend leads to smaller reductions in cold-related deaths

Warming climate trend leads to smaller reductions in cold-related deaths

A study by researchers at Columbia University's Mailman School of Public Health debunks the assumption that global warming will lead to a decline in the number of deaths in winter. Findings by Professor Patrick Kinney, ScD, professor of Environmental Health Sciences and director of the School's Climate and Health Program, showed that a warming climate trend led to much smaller reductions in cold-related mortality than some experts have anticipated. [More]
Researchers receive $1.1 million grant to pioneer novel approach to speed bone regeneration

Researchers receive $1.1 million grant to pioneer novel approach to speed bone regeneration

Senior citizens and combat soldiers don't usually have much in common--unless the topic is bone injuries. Among both groups, mending serious skeletal injuries--whether caused by a blast or a common fall--is a costly, complicated challenge. [More]
Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza Pharmaceuticals, Inc. today announced that it has updated and amended its ADASUVE (Staccato loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd. Ferrer is Alexza's commercial partner for ADASUVE in the European Union, Latin America, the Commonwealth of Independent States and other countries in Europe. [More]
Higher consumption of dietary trans fatty acids may affect memory

Higher consumption of dietary trans fatty acids may affect memory

Higher consumption of dietary trans fatty acids (dTFA), commonly used in processed foods to improve taste, texture and durability, has been linked to worsened memory function in men 45 years old and younger, according to a University of California, San Diego School of Medicine study published online on June 17 in PLOS ONE. [More]
New UT Southwestern research shows that exercise can improve diabetes control

New UT Southwestern research shows that exercise can improve diabetes control

Diabetics who exercise can trim waist size and body fat, and control blood glucose, even if they don't see cardiorespiratory benefits, new research by UT Southwestern Medical Center cardiologists shows. [More]
Advertisement
Advertisement